Regentatlantic Capital LLC Gsk PLC Transaction History

Regentatlantic Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $209,535 - $238,037	-4,983 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$40.23 - $47.74 $200,466 - $237,888	4,983 New	4,983 $217,000
Q4 2021 Jan 27, 2022	SELL	$38.88 - $45.31 $205,441 - $239,418	-5,284 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $204,966 - $228,057	5,284 New	5,284 $202,000
Q4 2020 Feb 04, 2021	SELL	$34.07 - $39.94 $569,684 - $667,836	-16,721 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$38.11 - $42.99 $447,792 - $505,132	11,750 Added 236.37%	16,721 $629,000
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $188,251 - $216,636	4,971 New	4,971 $203,000
Q4 2017 Jan 23, 2018	SELL	$35.34 - $41.9 $228,261 - $270,632	-6,459 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$39.44 - $41.55 $254,742 - $268,371	6,459	6,459 $262,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Regentatlantic Capital LLC with notifications on news.